Endothelial cells are highly heterogeneous at the level of cytokine-induced insulin resistance

Experimental Dermatology

Volumn 22, Issue 11, 2013, Pages 714-718

  Woth, Kathrin ^a   Prein, Claudia ^a   Steinhorst, Katja ^a   Diehl, Sandra ^a   Boehncke, Wolf Henning ^a,b   Buerger, Claudia ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cytokines; Endothelial cells; Heterogeneity; Insulin resistance; Psoriasis

Indexed keywords

CYTOKINE RECEPTOR; INSULIN; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC INFLAMMATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INSULIN RESPONSE; PSORIASIS;

CYTOKINES; ENDOTHELIAL CELLS; HETEROGENEITY; INSULIN RESISTANCE; PSORIASIS;

BRAIN; CELL LINE; CELL LINE, TRANSFORMED; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MICROCIRCULATION; PHENOTYPE; PLACENTA; PREGNANCY; PSORIASIS; SIGNAL TRANSDUCTION; SKIN;

EID: 84886793653     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12235     Document Type: Article

References (34)

1. Aird W C. Crit Care Med 2004: 32: S271-S279.
2. Zeng G Y, Quon M J. J Clin Invest 1996: 98: 894-898.
3. Hsueh W A, Lyon C J, Quinones M J. Am J Med 2004: 117: 109-117.
4. Aird W C. Cold Spring Harb Perspect Med 2012: 2: 1-13.
5. Zhao B T, Stavchansky S A, Bowden R A et al. Am J Physiol Cell Physiol 2003: 284: C1577-C1583.
6. Muniyappa R, Quon M J. Curr Opin Clin Nutr Metab Care 2007: 10: 523-530.
7. Shiojima I, Walsh K. Circ Res 2002: 90: 1243-1250.
8. Boehncke W H, Buerger C, Boehncke S. Hautarzt 2009: 60: 116-121.
9. Boura-Halfon S, Zick Y. J Clin Endocrinol Metab 2009: 296: E581-E591.
10. Montagnani M, Golovchenko I, Kim I et al. J Biol Chem 2002: 277: 1794-1799.
11. Taniguchi C M, Emanuelli B, Kahn C R. Nat Rev Mol Cell Biol 2006: 7: 85-96.
12. Sitia S, Tomasoni L, Atzeni F et al. Autoimmun Rev 2010: 9: 830-834.
13. Schon M P, Boehncke W H. N Engl J Med 2005: 352: 1899-1912.
14. Boehncke W-H, Boehncke S, Tobin A-M et al. Exp Dermatol 2011: 20: 303-307.
15. Boehncke S, Thaci D, Beschmann H et al. Br J Dermatol 2007: 157: 1249-1251.
16. Boehncke W H, Boehncke S, Schon M P. Br Med J 2010: 340: b5666.
17. Grimble R F. Curr Opin Clin Nutr Metab Care 2002: 5: 551-559.
18. Li J W, Chen X, Liu Z X et al. J Huazhong Univ Sci Technolog Med Sci 2007: 27: 330-332.
19. Gee K, Guzzo C, Che Mat N F et al. Inflamm Allergy Drug Targets 2009: 8: 40-52.
20. Butcher M, Galkina E. Thromb Haemost 2011: 106: 787-795.
21. Li G L, Barrett E J, Barrett M O et al. Endocrinology 2007: 148: 3356-3363.
22. Buerger C, Richter B, Woth K et al. J Invest Dermatol 2012: 132: 2206-2214.
23. Aird W C. Circ Res 2007: 100: 158-173.
24. Aird W C. Circ Res 2006: 98: 159-162.
25. Garlanda C, Dejana E. Arterioscler Thromb Vasc Biol 1997: 17: 1193-1202.
26. Schutz M, Teifel M, Friedl P. Eur J Cell Biol 1997: 74: 315-320.
27. Wallbrecht K, Drick N, Hund A-C et al. Exp Dermatol 2011: 20: 980-985.
28. Greiffenberg L, Goebel W, Kim K S et al. Infect Immun 1998: 66: 5260-5267.
29. Johansson G S, Chisalita S I, Arnqvist H J. Mol Cell Endocrinol 2008: 296: 58-63.
30. Cines D B, Pollak E S, Buck C A et al. Blood 1998: 91: 3527-3561.
31. Lang I, Pabst M A, Hiden U et al. Eur J Cell Biol 2003: 82: 163-173.
32. Stokes K Y, Granger D N. J Physiol 2005: 562: 647-653.
33. Gelfand J M, Neimann A L, Shin D B et al. JAMA 2006: 296: 1735-1741.
34. Ludwig R J, Herzog C, Rostock A et al. Br J Dermatol 2007: 156: 271-276.